| Nome |
# |
|
Protein corona and nanoparticles: How can we investigate on?, file e31e124c-78c5-987f-e053-3705fe0a095a
|
1.098
|
|
Novel Curcumin loaded nanoparticles engineered for Blood-Brain Barrier crossing and able to disrupt Abeta aggregates, file e31e124c-cee9-987f-e053-3705fe0a095a
|
879
|
|
How does “Protein Corona” Affect the In vivo Efficiency of Polymeric Nanoparticles? State of Art, file e31e124d-13a1-987f-e053-3705fe0a095a
|
829
|
|
Protein cage nanostructure as drug delivery system: magnifying glass on apoferritin, file e31e124b-eba1-987f-e053-3705fe0a095a
|
699
|
|
Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders, file e31e124d-2485-987f-e053-3705fe0a095a
|
459
|
|
AFM, ESEM, TEM and CLSM in liposomal characterization: a comparative study, file e31e124a-ab87-987f-e053-3705fe0a095a
|
372
|
|
Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery, file e31e124d-11fc-987f-e053-3705fe0a095a
|
366
|
|
AFM phase imaging of soft-hydrated samples: A versatile tool to complete the chemical-physical study of liposomes, file e31e124b-2b29-987f-e053-3705fe0a095a
|
303
|
|
Apoferritin nanocage as streptomycin drug reservoir: Technological optimization of a new drug delivery system, file e31e124c-7852-987f-e053-3705fe0a095a
|
296
|
|
Nanotechnology-based drug delivery systems for Alzheimer's disease management: Technical, industrial, and clinical challenges, file e31e1250-3d53-987f-e053-3705fe0a095a
|
265
|
|
Nanoparticle transport across the blood brain barrier, file e31e124b-fd98-987f-e053-3705fe0a095a
|
254
|
|
PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study, file e31e124e-7abd-987f-e053-3705fe0a095a
|
234
|
|
Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice, file e31e124b-2850-987f-e053-3705fe0a095a
|
208
|
|
Targeted polymeric nanoparticles for brain delivery of high molecular weight molecules in lysosomal storage disorders, file e31e124b-c7b2-987f-e053-3705fe0a095a
|
203
|
|
Targeting Brain Disease in MPSII: Preclinical Evaluation of IDS-Loaded PLGA Nanoparticles, file e31e124d-b195-987f-e053-3705fe0a095a
|
183
|
|
AFM/TEM complementary structural analysis of surface-functionalized nanoparticles, file e31e124b-2afe-987f-e053-3705fe0a095a
|
179
|
|
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity, file e31e124b-e9b6-987f-e053-3705fe0a095a
|
175
|
|
Apoferritin nanocage as drug reservoir: is it a reliable drug delivery system?, file e31e124b-f096-987f-e053-3705fe0a095a
|
168
|
|
Tween® preserves enzyme activity and stability in PLGA nanoparticles, file e31e124f-c04a-987f-e053-3705fe0a095a
|
158
|
|
Development of novel Zn2+ loaded nanoparticles designed for cell-type targeted drug release in CNS neurons: in vitro evidences., file e31e124a-ae80-987f-e053-3705fe0a095a
|
128
|
|
Detection of PLGA-based nanoparticles at single cell level by Synchrotron Radiation FTIR Spectromicroscopy and correlation with X-Ray Fluorescence Microscopy, file e31e124a-a510-987f-e053-3705fe0a095a
|
126
|
|
Delivering the power of nanomedicine to patients today, file e31e124e-79a8-987f-e053-3705fe0a095a
|
125
|
|
Synthesis, Characterization, and In Vitro Studies of an Reactive Oxygen Species (ROS)-Responsive Methoxy Polyethylene Glycol-Thioketal-Melphalan Prodrug for Glioblastoma Treatment, file e31e124e-8939-987f-e053-3705fe0a095a
|
120
|
|
Applications of the ROS-Responsive Thioketal Linker for the Production of Smart Nanomedicines, file b1d3d03b-203b-4c58-acc7-8621ed0d3638
|
115
|
|
Nerve Growth Factor Biodelivery: A Limiting Step in Moving Toward Extensive Clinical Application?, file e31e124f-da0a-987f-e053-3705fe0a095a
|
113
|
|
Investigating Novel Syntheses of a Series of Unique Hybrid PLGA-Chitosan Polymers for Potential Therapeutic Delivery Applications, file e31e124e-73fa-987f-e053-3705fe0a095a
|
109
|
|
Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain, file e31e124b-fe37-987f-e053-3705fe0a095a
|
100
|
|
Optimization of an Injectable Hydrogel Depot System for the Controlled Release of Retinal-Targeted Hybrid Nanoparticles, file de56d3fd-4d7b-42c5-9e9d-6cf1424994de
|
96
|
|
The apple snail Pomacea canaliculata: a new and alternative animal model for testing innovative nanomedicines, file e31e124f-4f5d-987f-e053-3705fe0a095a
|
74
|
|
PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting, file e31e1250-aac7-987f-e053-3705fe0a095a
|
56
|
|
Microfluidic technology for the production of hybrid nanomedicines, file e31e124f-c44c-987f-e053-3705fe0a095a
|
50
|
|
Nanomedicine-based technologies and novel biomarkers for the diagnosis and treatment of Alzheimer’s disease: from current to future challenges, file e31e124f-da08-987f-e053-3705fe0a095a
|
45
|
|
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles, file e31e124c-47de-987f-e053-3705fe0a095a
|
39
|
|
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma, file e31e124d-a1f5-987f-e053-3705fe0a095a
|
32
|
|
Insights into healthcare professionals’ perceptions and attitudes toward nanotechnological device application: What is the current situation in glioblastoma research?, file 8662c3c3-2c26-4c4f-8ede-172ef86ea45c
|
30
|
|
Glioblastoma Multiforme Selective Nanomedicines for Improved Anti-Cancer Treatments, file 076f10e4-95b5-476f-ab7c-eaf18862aaac
|
29
|
|
Recent Advances on Surface-Modified GBM Targeted Nanoparticles: Targeting Strategies and Surface Characterization, file 3c9c2fb7-3a02-4405-a780-faa9f3b73d59
|
23
|
|
Chemico-physical investigation of tenofovir loaded polymeric nanoparticles, file e31e124a-a629-987f-e053-3705fe0a095a
|
22
|
|
Nanomedicine against Aβ aggregation by β–sheet breaker peptide delivery: In vitro evidence, file e31e124d-f35e-987f-e053-3705fe0a095a
|
17
|
|
"Combo" Multi-Target Pharmacological Therapy and New Formulations to Reduce Inflammation and Improve Endogenous Remyelination in Traumatic Spinal Cord Injury, file ae6c228a-ecbc-4620-8d74-6ada16e242c3
|
15
|
|
Chronic cholesterol administration to the brain supports complete and long-lasting cognitive and motor amelioration in Huntington's disease, file 921ecac0-f491-4d85-a8ce-3144fafd9178
|
14
|
|
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes, file e31e124a-b003-987f-e053-3705fe0a095a
|
13
|
|
Tunneling Nanotubes: A New Target for Nanomedicine?, file b85e608a-6229-4c1c-b9ef-09ecd8387e77
|
12
|
|
Quantitative comparison of the protein corona of nanoparticles with different matrices, file e60a9f5f-7769-4bcc-a35c-47240f3cf27d
|
10
|
|
NEUROTROPHIC FACTORS AND NEURODEGENERATIVE DISEASES: A DELIVERY ISSUE, file e31e124a-af12-987f-e053-3705fe0a095a
|
9
|
|
Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release, file e31e124a-a708-987f-e053-3705fe0a095a
|
7
|
|
Implantable SDF-1α-loaded silk fibroin hyaluronic acid aerogel sponges as an instructive component of the glioblastoma ecosystem: between chemoattraction and tumor shaping into resection cavities, file 97999546-73bf-4871-83ab-8ae4b8669f52
|
6
|
|
Enzyme Stability in Nanoparticle Preparations Part 1: Bovine Serum Albumin Improves Enzyme Function, file a3bc5388-a55e-4989-af86-9a32134c138d
|
6
|
|
Application of atomic force microscopy to characterize liposomes as drug and gene carriers, file e31e124a-99ca-987f-e053-3705fe0a095a
|
6
|
|
PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting, file e31e124b-3178-987f-e053-3705fe0a095a
|
6
|
|
The bridge between Nanotechnology and Neuroscience: Neuro-Nanomedicine, file e31e124a-b178-987f-e053-3705fe0a095a
|
5
|
|
Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments, file e31e124b-3144-987f-e053-3705fe0a095a
|
5
|
|
Hyaluronic Acid Scaffolds for Loco-Regional Therapy in Nervous System Related Disorders, file 7e4e077d-b7d9-45ce-b339-415202c969c4
|
4
|
|
Colloidal systems for CNS drug delivery, file e31e124a-a126-987f-e053-3705fe0a095a
|
4
|
|
AFM and TEM characterization of siRNAs lipoplexes: a combinatory tools to predict the efficacy of complexation, file e31e124a-a570-987f-e053-3705fe0a095a
|
4
|
|
Brain-targeted polymeric nanoparticles: in vivo evidences after different routes of administration in rodents., file e31e124a-a619-987f-e053-3705fe0a095a
|
4
|
|
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma, file e31e124a-aa8a-987f-e053-3705fe0a095a
|
4
|
|
Sialic Acid as a potential approach for the protection and targeting of nanocarriers, file e31e124a-af06-987f-e053-3705fe0a095a
|
4
|
|
Use of Polylactide-Co-Glycolide-Nanoparticles for Lysosomal Delivery of a Therapeutic Enzyme in Glycogenosis Type II Fibroblasts, file e31e124b-3111-987f-e053-3705fe0a095a
|
4
|
|
Biocatalytic asymmetric synthesis of (S)- and (R)-Timolol, file e31e124a-962c-987f-e053-3705fe0a095a
|
3
|
|
Dotap/Udca vesicles: novel approach in oligonucleotide delivery, file e31e124a-9827-987f-e053-3705fe0a095a
|
3
|
|
Nanoparticles as drug delivery agents specific for CNS: in vivo biodistribution, file e31e124a-9da6-987f-e053-3705fe0a095a
|
3
|
|
Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution, file e31e124a-a50d-987f-e053-3705fe0a095a
|
3
|
|
Nuclear localization of cationic solid lipid nanoparticles containing Protamine as transfection promoter, file e31e124a-aaa1-987f-e053-3705fe0a095a
|
3
|
|
Apoferritin nanocage as drug reservoir: is it a reliable drug delivery system?, file e31e124b-f655-987f-e053-3705fe0a095a
|
3
|
|
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach, file e31e124c-e424-987f-e053-3705fe0a095a
|
3
|
|
Protein corona and nanoparticles: How can we investigate on?, file e31e124f-e216-987f-e053-3705fe0a095a
|
3
|
|
Nanoparticle formulation may affect the stabilization of an antiischemic prodrug, file e31e124a-9547-987f-e053-3705fe0a095a
|
2
|
|
Targeting the Central Nervous System: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123, file e31e124a-99cb-987f-e053-3705fe0a095a
|
2
|
|
Nanoparticulate drug carriers based on hybrid poly(D,L-lactide-co-glycolide)-dendron structures, file e31e124a-9e25-987f-e053-3705fe0a095a
|
2
|
|
Collagen modified based membranes for tissue engineering: influence of type and molecular weight of GAGs on cell proliferation, file e31e124a-a04b-987f-e053-3705fe0a095a
|
2
|
|
Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport, file e31e124a-a50e-987f-e053-3705fe0a095a
|
2
|
|
Brain targeting with polymeric nanoparticles: which administration route should we take?, file e31e124a-a56f-987f-e053-3705fe0a095a
|
2
|
|
Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrier., file e31e124a-a9a5-987f-e053-3705fe0a095a
|
2
|
|
NIR-labeled nanoparticles engineered for brain targeting: in vivo optical imaging application and fluorescent microscopy evidences., file e31e124a-ab86-987f-e053-3705fe0a095a
|
2
|
|
APPLICATION OF POLY-L-LACTIDE SCREWS IN FLAT FOOT SURGERY: HISTOLOGICAL AND RADIOLOGICAL ASPECTS OF BIO-ABSORPTION OF DEGRADABLE DEVICES., file e31e124a-abbf-987f-e053-3705fe0a095a
|
2
|
|
Nanomedicine: the future for advancing medicine and neuroscience, file e31e124a-add7-987f-e053-3705fe0a095a
|
2
|
|
The loading of labeled antibody engineered nanoparticles with Indinavir increases its in vitro efficacy against Cryptosporidium parvum, file e31e124a-b001-987f-e053-3705fe0a095a
|
2
|
|
Emerging use of nanotechnology in the treatment of neurological disorders, file e31e124b-2857-987f-e053-3705fe0a095a
|
2
|
|
PLGA Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation of the Effect of Storage and Serum Stability with Reference to Traumatic Brain Injury, file e31e124b-29f0-987f-e053-3705fe0a095a
|
2
|
|
Nanoimaging: photophysical and pharmaceutical characterization of poly-lactide-co-glycolide nanoparticles engineered with quantum dots, file e31e124b-2af5-987f-e053-3705fe0a095a
|
2
|
|
Nanotechnology and Alzheimer’s disease: What has been done and what to do’, file e31e124b-2ba1-987f-e053-3705fe0a095a
|
2
|
|
Nanomedicine and neurodegenerative disorders: So close yet so far, file e31e124b-2f6e-987f-e053-3705fe0a095a
|
2
|
|
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma, file e31e124b-30fd-987f-e053-3705fe0a095a
|
2
|
|
The “fate” of polymeric and lipid nanoparticles for brain delivery and targeting: Strategies and mechanism of blood–brain barrier crossing and trafficking into the central nervous system, file e31e124b-3103-987f-e053-3705fe0a095a
|
2
|
|
Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain, file e31e124b-e9bc-987f-e053-3705fe0a095a
|
2
|
|
ROS-responsive “smart” polymeric conjugate: Synthesis, characterization and proof-of-concept study, file e31e124d-f46e-987f-e053-3705fe0a095a
|
2
|
|
Preparation and characterization of particulate drug delivery systems for the brain targeting, file e31e124a-96fb-987f-e053-3705fe0a095a
|
1
|
|
Chemo-enzymatic synthesis of levodropropizine, file e31e124a-9713-987f-e053-3705fe0a095a
|
1
|
|
Atomic force microscopy and photon correlation spectroscopy: Two techniques for rapid characterization of liposomes, file e31e124a-9784-987f-e053-3705fe0a095a
|
1
|
|
Liposome-oligonucleotides interaction for in vitro uptake by COSI and HaCaT cells, file e31e124a-97a7-987f-e053-3705fe0a095a
|
1
|
|
Conjugated poly(D,L-lactide-co-glycolide) for the preparation of in vivo detectable nanoparticles, file e31e124a-9e89-987f-e053-3705fe0a095a
|
1
|
|
Vegetable cells in Papanicolaou-stained cervical smears, file e31e124a-9e9f-987f-e053-3705fe0a095a
|
1
|
|
Peptide-derivatized biodegradable nanoparticles able to cross the blood-brain barrier, file e31e124a-9ece-987f-e053-3705fe0a095a
|
1
|
|
Polymeric nanoparticles for the drug delivery to the central nervous system, file e31e124a-9fc8-987f-e053-3705fe0a095a
|
1
|
|
Flow cytometry and live confocal analysis for the evaluation of the uptake and intracellular distribution of FITC-ODN into HaCaT cells, file e31e124a-a049-987f-e053-3705fe0a095a
|
1
|
|
PLGA nanoparticles surface decorated with the sialic acid, N-acetylneuraminic acid, file e31e124a-a168-987f-e053-3705fe0a095a
|
1
|
|
Biodegradable device applied in flatfoot surgery: Comparative studies between
clinical and technological aspects of removed screws, file e31e124a-a317-987f-e053-3705fe0a095a
|
1
|
|
Immunoliposomal systems targeting the primary effusion lymphoma (PEL): in vitro study, file e31e124a-aa89-987f-e053-3705fe0a095a
|
1
|
|
Investigation on Mechanisms of Glycopeptide Nanoparticles for Drug Delivery across the Blood-Brain Barrier, file e31e124a-ad08-987f-e053-3705fe0a095a
|
1
|
| Totale |
8.996 |
